P-162 Interim Results of IMMU-132 (Sacituzumab Govitecan), an Anti-Trop-2 Antibody-Drug Conjugate (ADC), in Patients (pts) with Metastatic Gastrointestinal (GI) Cancers
作者
Allyson J. Ocean,Alexander Starodub,Wells A. Messersmith,Vincent J. Picozzi,M. Guarino,Sajeve Samuel Thomas,Aditya Bardia,Manish A. Shah,Serengulam V. Govindan,Pius P. Maliakal,William A. Wegener,Robert M. Sharkey,Francois E. Wilhelm,David M. Goldenberg